Literature DB >> 18331842

Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.

Laith Q Al-Mawsawi1, Frauke Christ, Raveendra Dayam, Zeger Debyser, Nouri Neamati.   

Abstract

A lens epithelium-derived growth factor (LEDGF)/p75 peptide was evaluated for human immunodeficiency virus type 1 integrase (IN) inhibitory activity. The LEDGF/p75 peptide modestly inhibited IN catalysis and was dependent on IN-DNA assembly. The peptide was also effective at disrupting LEDGF/p75-IN complex formation. We next investigated the activity of the LEDGF/p75 peptide on IN mutant proteins that are unable to catalyze the DNA strand transfer reaction. The LEDGF/p75 peptide displayed an increased potency on these IN proteins, from 5-fold to greater than 10-fold, indicating the IN multimeric state greatly influences the peptide inhibitory effects. These results shed light on IN-DNA multimeric formation, and how this process influences the LEDGF/p75-IN interaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18331842     DOI: 10.1016/j.febslet.2008.02.076

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Allosteric inhibitor development targeting HIV-1 integrase.

Authors:  Laith Q Al-Mawsawi; Nouri Neamati
Journal:  ChemMedChem       Date:  2011-01-12       Impact factor: 3.466

2.  Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects.

Authors:  S P Korolev; Yu Yu Agapkina; M B Gottikh
Journal:  Acta Naturae       Date:  2011-07       Impact factor: 1.845

3.  Biochemical and biophysical analyses of concerted (U5/U3) integration.

Authors:  Duane P Grandgenett; Sibes Bera; Krishan K Pandey; Ajaykumar C Vora; Jacob Zahm; Sapna Sinha
Journal:  Methods       Date:  2008-11-29       Impact factor: 3.608

Review 4.  HIV integrase inhibitors: 20-year landmark and challenges.

Authors:  Mathieu Métifiot; Christophe Marchand; Yves Pommier
Journal:  Adv Pharmacol       Date:  2013

5.  Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein.

Authors:  Christopher J McKee; Jacques J Kessl; Nikolozi Shkriabai; Mohd Jamal Dar; Alan Engelman; Mamuka Kvaratskhelia
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

6.  Affinities between the binding partners of the HIV-1 integrase dimer-lens epithelium-derived growth factor (IN dimer-LEDGF) complex.

Authors:  Manuel Tsiang; Gregg S Jones; Magdeleine Hung; Susmith Mukund; Bin Han; Xiaohong Liu; Kerim Babaoglu; Eric Lansdon; Xiaowu Chen; Jacob Todd; Terrence Cai; Nikos Pagratis; Roman Sakowicz; Romas Geleziunas
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

Review 7.  HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.

Authors:  Paul Spearman
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

8.  An allosteric mechanism for inhibiting HIV-1 integrase with a small molecule.

Authors:  Jacques J Kessl; Jocelyn O Eidahl; Nikolozi Shkriabai; Zhuojun Zhao; Christopher J McKee; Sonja Hess; Terrence R Burke; Mamuka Kvaratskhelia
Journal:  Mol Pharmacol       Date:  2009-07-28       Impact factor: 4.436

9.  Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells.

Authors:  Dimitrios N Vatakis; Sanggu Kim; Namshin Kim; Samson A Chow; Jerome A Zack
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

10.  Design of cell-permeable stapled peptides as HIV-1 integrase inhibitors.

Authors:  Ya-Qiu Long; Shao-Xu Huang; Zahrah Zawahir; Zhong-Liang Xu; Huiyuan Li; Tino W Sanchez; Ying Zhi; Stephanie De Houwer; Frauke Christ; Zeger Debyser; Nouri Neamati
Journal:  J Med Chem       Date:  2013-06-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.